Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 44 results

research Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

26 citations , October 2019 in “JNCI Cancer Spectrum”

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

research Relationships, Intimacy, and Body Image After Breast Cancer

September 2016 in “Oncology times”

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

research Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management

October 2014 in “Journal of Minimally Invasive Gynecology”

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

research The North American Menopause Society Recommendations for Clinical Care of Midlife Women

254 citations , September 2014 in “Menopause”

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

research Effect of Finasteride on Prostate-Specific Antigen

2 citations , December 2006 in “Lancet Oncology”

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

View more "brca mutations" in research →

Community Join

1 / 1 results

community One and a half year on meds (fin/dut, minox)

in Progress Pictures 54 upvotes 1 year ago

The user has been using oral minoxidil, finasteride, and dutasteride to prevent hair loss, despite not showing significant balding. Many commenters believe the treatment is excessive, while some support early prevention.